Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
US9193749B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 14, 2013 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | Oct 4, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H13/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I)whereinQ, J, L and Z are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.